HLS Therapeutics Inc. (OTCMKTS:HLTRF) Sees Large Drop in Short Interest

HLS Therapeutics Inc. (OTCMKTS:HLTRF) was the target of a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 900 shares, a drop of 43.8% from the August 31st total of 1,600 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 9.0 days.

HLS Therapeutics Stock Performance

HLS Therapeutics stock remained flat at $2.60 during trading hours on Thursday. 100 shares of the company’s stock traded hands, compared to its average volume of 710. The company’s fifty day moving average is $2.38 and its two-hundred day moving average is $2.82. HLS Therapeutics has a 1 year low of $2.22 and a 1 year high of $4.00.

About HLS Therapeutics

HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.